EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection

Zahra Khosravi, Farnaz Barzinpour iD, Soghra Rabizadeh, Manouchehr Nakhjavani, Alireza Esteghamati

PLOS One · 2026

DOI: 10.1371/journal.pone.0339580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Zahra Khosravi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Industrial Engineering, Iran University of Science and Technology, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Machine Learning, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-Associated Fatty Liver Disease (MAFLD) is common among Type 2 Diabetes (T2DM) patients. The coexistence of these conditions increases the risk of MAFLD progression and diabetes complications. Detecting MAFLD early is challenging due to its asymptomatic initial stages. In this study, we aimed to develop a machine learning model to predict MAFLD in T2DM patients. We conducted a cross-sectional study on 3,654 Iranian T2DM patients using their demographic and lab data. This study involved thorough data preprocessing, including evaluating various imputation methods on simulated missingness in a complete subset of the dataset. Additionally, four feature selection methods were applied to eight machine learning models to identify the most effective predictive model. The XGBoost classifier without feature selection achieved the best performance, with an accuracy of 80.6% and an area under the receiver operating characteristic curve (AUC) of 88.9%.Notably, certain features, such as alanine aminotransferase (ALT), platelet count (PLT) and Vitamin D(VitD) influenced the predictive performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Machine LearningNon-alcoholic Fatty Liver DiseaseHumansMaleFemalePredictive Learning ModelsCross-Sectional StudiesBoosting Machine Learning AlgorithmsMiddle AgedROC CurveAlanine TransaminasePrediction AlgorithmsClassification AlgorithmsIranAdultData Analytics

Substanzen

Alanine Transaminase

Autor:innen und Institutionen

  • School of Industrial Engineering, Iran University of Science and Technology, Tehran, Iran.
  • Endocrinology and Metabolism Research Center (EMRC), Imam Khomeini Hospital Complex, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Farnaz Barzinpour

Zitieren

APA

Khosravi, Z., Barzinpour, F., Rabizadeh, S., Nakhjavani, M., & Esteghamati, A. (2026). Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection. PLOS One. https://doi.org/10.1371/journal.pone.0339580

Vancouver

Khosravi Z, Barzinpour F, Rabizadeh S, Nakhjavani M, Esteghamati A. Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection. PLOS One. 2026. doi:10.1371/journal.pone.0339580

BibTeX
@article{Khosravi2026,
  author = {Khosravi, Zahra and Barzinpour, Farnaz and Rabizadeh, Soghra and Nakhjavani, Manouchehr and Esteghamati, Alireza},
  title = {Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0339580}
}
Kostenlos starten →